Literature DB >> 12432944

Leukotriene B4 receptors.

Akiko Toda1, Takehiko Yokomizo, Takao Shimizu.   

Abstract

Leukotriene B4 (LTB4) is a potent chemotactic agent and activating factor for granulocytes. Two cell surface receptors for LTB4 (BLT1 and BLT2) have been isolated in the last few years. These receptors are G-protein-coupled receptors (GPCR), and they have 45% amino acid identity. BLT1 and BLT2 are high- and low- affinity receptors, respectively. Cells transfected with BLT1 and BLT2 show LTB4-dependent intracellular signal transduction and chemotaxis in vitro. The distribution and pharmacological characteristics of BLT1 and BLT2 are different, suggesting distinct roles for these receptors in vivo. The open reading frame (ORF) of BLT2 overlaps the promoter of BLT1, a so called 'promoter in ORF'. Based on recent publications on BLT1 transgenic and knock out mice phenotypes, it appears that LTB4 plays important roles in inflammation in addition to host defense in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12432944     DOI: 10.1016/s0090-6980(02)00056-4

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  28 in total

1.  Engineering a G protein-coupled receptor for structural studies: stabilization of the BLT1 receptor ground state.

Authors:  Aimée Martin; Marjorie Damian; Michel Laguerre; Joseph Parello; Bernard Pucci; Laurence Serre; Sophie Mary; Jacky Marie; Jean-Louis Banères
Journal:  Protein Sci       Date:  2009-04       Impact factor: 6.725

2.  Real-time imaging of leukotriene B₄ mediated cell migration and BLT1 interactions with β-arrestin.

Authors:  Venkatakrishna R Jala; Bodduluri Haribabu
Journal:  J Vis Exp       Date:  2010-12-23       Impact factor: 1.355

3.  Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression.

Authors:  Venkatakrishna R Jala; Paramahamsa Maturu; Sobha R Bodduluri; Elangovan Krishnan; Steven Mathis; Krishnaprasad Subbarao; Min Wang; Alfred B Jenson; Mary L Proctor; Eric C Rouchka; Rob Knight; Bodduluri Haribabu
Journal:  Oncoimmunology       Date:  2017-08-10       Impact factor: 8.110

Review 4.  Radiotracers used for the scintigraphic detection of infection and inflammation.

Authors:  Chris Tsopelas
Journal:  ScientificWorldJournal       Date:  2015-02-08

Review 5.  Bioactive Fatty Acids in the Resolution of Chronic Inflammation in Skin Wounds.

Authors:  Carlos Poblete Jara; Natália Ferreira Mendes; Thais Paulino do Prado; Eliana Pereira de Araújo
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-06-23       Impact factor: 4.730

6.  Leukotriene B4 mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats.

Authors:  Steven R Vigna; Rafiq A Shahid; Jaimie D Nathan; Douglas C McVey; Rodger A Liddle
Journal:  Pancreas       Date:  2011-07       Impact factor: 3.327

7.  Anethole and eugenol reduce in vitro and in vivo leukocyte migration induced by fMLP, LTB4, and carrageenan.

Authors:  Camila Fernanda Estevão-Silva; Raquel Kummer; Fernanda Carolina Fachini-Queiroz; Renata Grespan; Gessilda Alcântara Nogueira de Melo; Silmara Baroni; Roberto Kenji Nakamura Cuman; Ciomar Aparecida Bersani-Amado
Journal:  J Nat Med       Date:  2014-05-01       Impact factor: 2.343

8.  Murine 12/15-lipoxygenase regulates ATP-binding cassette transporter G1 protein degradation through p38- and JNK2-dependent pathways.

Authors:  Melissa H Nagelin; Suseela Srinivasan; Jerry L Nadler; Catherine C Hedrick
Journal:  J Biol Chem       Date:  2009-08-27       Impact factor: 5.157

9.  Susceptibility to endotoxin induced uveitis is not reduced in mice deficient in BLT1, the high affinity leukotriene B4 receptor.

Authors:  J R Smith; K Subbarao; D T Franc; B Haribabu; J T Rosenbaum
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

10.  Oxidative stress-induced changes in pyridine nucleotides and chemoattractant 5-lipoxygenase products in aging neutrophils.

Authors:  François D Graham; Karl-Rudolf Erlemann; Sylvie Gravel; Joshua Rokach; William S Powell
Journal:  Free Radic Biol Med       Date:  2009-04-17       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.